#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Pituitary-dependent Cushing's syndrome Atopic keratoconjunctivitis Crohn's disease Acquired C1 inhibitor deficiency Brain stem glioma Testicular leiomyosarcoma Cutaneous T-cell lymphoma refractory Hyperinsulinaemic hypoglycaemia Frontotemporal dementia Antiphospholipid antibodies Obliterative bronchiolitis Cardiac failure acute Carcinoid syndrome Glycogen storage disease type I Pericarditis More trials…

    Learn about Rare Diseases

    Splenic marginal zone lymphoma Shprintzen-Goldberg syndrome – Diagnostics Andersen-Tawil syndrome – Diagnostics Ewing’s sarcoma recurrent – Trials in Disease Progressive multifocal leukoencephalopathy – Trials in Disease Burkitt’s lymphoma – Diagnostics Paraneoplastic neurological syndrome Marginal zone lymphoma refractory – Diagnostics Congenital generalised lipodystrophy – Treatment Skin angiosarcoma – Basic Information More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Magnesium Chloride 10-1074-Ls Ademetionine Naproxen Propylene Glycol Cls12311 Indacaterol INOBRODIB Crinecerfont Tramadol L-Histidine Bimatoprost Ciclosporin GS-248 Glycine Linerixibat Bms-986340 Vx-670 BUDOPRUTUG SAT-3247 OXALATE More therapies…

    Learn about Your Condition

    Chorioretinitis Ewing's sarcoma metastatic Trisomy 21 HER2 positive gastric cancer Kearns-Sayre syndrome Mechanical ventilation Aplastic anaemia Infectious pleural effusion Childhood asthma Adenocarcinoma of colon Rosai-Dorfman syndrome Hypertrophic cardiomyopathy Staphylococcal infection Pre-eclampsia Pancreatic carcinoma recurrent More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Cardiomyopathy

  • A Study Comparing Gadopiclenol and Gadoterate Meglumine for Heart MRI Scans in Children with Congenital Heart Disease

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Cardiomyopathy
    Investigated Drugs:
    • Meglumine Gadoterate
    Spain

  • A study testing ninerafaxstat compared to placebo in patients with symptomatic non-obstructive hypertrophic cardiomyopathy

    Recruiting

    2 1
    Investigated Diseases:
    • Cardiomyopathy
    • Hypertrophic cardiomyopathy
    Austria Belgium France Germany Italy The Netherlands +3

  • Study of stopping heart failure medications in patients with non-ischemic cardiomyopathy who responded very well to cardiac resynchronization therapy

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Cardiomyopathy
    Investigated Drugs:
    • Altizide
    • Atenolol
    • Bisoprolol Fumarate
    Spain

  • Study of Nucresiran in Adults with Transthyretin Amyloidosis with Cardiomyopathy to Evaluate its Effects on Survival and Heart Problems

    Recruiting

    3 1
    Investigated Diseases:
    • Cardiomyopathy
    Austria Belgium Czechia Denmark France Germany +12

  • Study on Valsartan and Sacubitril for Preventing Disease Progression in Patients with Arrhythmogenic Right Ventricular Cardiomyopathy (ARVC)

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Cardiomyopathy
    Investigated Drugs:
    • Sacubitril
    • Valsartan
    Poland

  • Study on Colchicine for Treating Patients with Inflammatory Cardiomyopathy

    Not yet recruiting

    3 1 1
    Investigated Diseases:
    • Cardiomyopathy
    Investigated Drugs:
    • Colchicine
    Italy
1 2
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!